Share Price and Basic Stock Data
Last Updated: January 2, 2026, 7:31 pm
| PEG Ratio | 0.56 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Himadri Speciality Chemical Ltd operates in the specialty chemicals sector, focusing on the production of a diverse range of chemical products. The company reported a significant increase in sales, rising from ₹2,791 Cr in FY 2022 to ₹4,172 Cr in FY 2023, indicating a robust growth trajectory. The trailing twelve months (TTM) sales stood at ₹4,465 Cr, demonstrating sustained revenue generation. Quarterly sales showed fluctuations, with a peak of ₹1,177 Cr in March 2024 and a slight decline to ₹951 Cr in June 2023, before rebounding to ₹1,005 Cr in September 2023. The operating profit margin (OPM) improved from 10% in FY 2023 to 19% in FY 2025, reflecting enhanced operational efficiency. The company’s ability to adapt to market demands has been a critical factor in achieving these revenue milestones, positioning Himadri as a competitive player in the specialty chemicals market.
Profitability and Efficiency Metrics
The profitability metrics for Himadri Speciality Chemical Ltd portray a positive outlook, with net profit for FY 2025 recorded at ₹652 Cr, up from ₹216 Cr in FY 2023. The earnings per share (EPS) also rose significantly from ₹4.99 in FY 2023 to ₹11.26 in FY 2025. The return on equity (ROE) stood at 16.4%, while the return on capital employed (ROCE) was reported at 22%, showcasing effective capital utilization. The interest coverage ratio (ICR) was notably high at 20.23x, indicating strong ability to meet interest obligations. These figures highlight the company’s operational efficiency and profitability, as reflected in its improved financial ratios. The cash conversion cycle (CCC) remains manageable at 90 days, suggesting effective management of working capital. Overall, these metrics place Himadri above typical sector performance, reflecting its strong operational capabilities.
Balance Sheet Strength and Financial Ratios
The balance sheet of Himadri Speciality Chemical Ltd demonstrates a solid financial position, with total assets reported at ₹5,518 Cr and total liabilities at ₹4,656 Cr for FY 2025. The company’s reserves rose significantly from ₹2,237 Cr in FY 2023 to ₹4,020 Cr in September 2025, indicating strong retained earnings and a healthy equity capital of ₹49 Cr. The debt levels remained low, with borrowings at ₹864 Cr, translating to a total debt-to-equity ratio of 0.08, indicating minimal reliance on debt financing. The current ratio stood at 3.56, reflecting strong liquidity, while the quick ratio was reported at 2.59, indicating solid short-term financial health. These financial ratios suggest that Himadri is well-positioned to meet its obligations and invest in growth opportunities, enhancing its overall financial resilience.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Himadri Speciality Chemical Ltd reveals a stable structure with promoters holding 52.50% of the equity as of November 2025. This represents an increase from 45.61% in March 2023, indicating growing confidence from the promoters in the company’s future performance. Foreign institutional investors (FIIs) held 5.62%, while domestic institutional investors (DIIs) accounted for 3.18%, suggesting a moderate level of institutional interest. The public shareholding stood at 38.69%, reflecting a diverse ownership base. The number of shareholders rose to 4,44,893, indicating increasing retail investor interest. This growing investor confidence is likely driven by the company’s strong financial performance and growth potential, which can be crucial for future capital raising initiatives.
Outlook, Risks, and Final Insight
The outlook for Himadri Speciality Chemical Ltd appears promising, supported by robust revenue growth and improving profitability metrics. However, risks such as fluctuating raw material prices and potential regulatory challenges in the chemicals sector could impact margins. Additionally, maintaining operational efficiency to sustain profitability in a competitive market remains critical. Should Himadri continue to innovate and expand its product offerings, it is poised for further growth. Conversely, any significant downturn in demand or adverse market conditions could impede its performance. The company’s solid balance sheet and strong cash flows provide a buffer against these risks, allowing it to navigate potential challenges effectively while capitalizing on growth opportunities in the specialty chemicals market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 391 Cr. | 42.7 | 80.9/40.0 | 24.3 | 20.5 | 0.94 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 31.7 Cr. | 64.5 | 88.8/56.0 | 15.2 | 89.6 | 1.55 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 49.4 Cr. | 726 | 932/600 | 22.8 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,700 Cr. | 81.6 | 111/68.2 | 24.5 | 22.0 | 0.61 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 637 Cr. | 256 | 393/230 | 22.9 | 93.8 | 0.98 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,925.12 Cr | 718.97 | 67.23 | 183.02 | 0.43% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,059 | 1,037 | 1,029 | 951 | 1,005 | 1,053 | 1,177 | 1,200 | 1,137 | 1,141 | 1,135 | 1,118 | 1,071 |
| Expenses | 962 | 932 | 903 | 817 | 847 | 879 | 997 | 1,008 | 929 | 920 | 901 | 873 | 838 |
| Operating Profit | 97 | 105 | 126 | 134 | 158 | 174 | 180 | 192 | 208 | 221 | 233 | 245 | 233 |
| OPM % | 9% | 10% | 12% | 14% | 16% | 17% | 15% | 16% | 18% | 19% | 21% | 22% | 22% |
| Other Income | -22 | 8 | 11 | 10 | 10 | 10 | 12 | 13 | 14 | 12 | 14 | 27 | 36 |
| Interest | 20 | 20 | 13 | 13 | 16 | 21 | 14 | 13 | 11 | 12 | 9 | 16 | 15 |
| Depreciation | 13 | 13 | 12 | 12 | 12 | 13 | 13 | 13 | 13 | 15 | 14 | 15 | 17 |
| Profit before tax | 42 | 79 | 111 | 119 | 139 | 150 | 166 | 179 | 197 | 206 | 224 | 241 | 237 |
| Tax % | 15% | 18% | 31% | 28% | 28% | 28% | 30% | 31% | 31% | 31% | 31% | 26% | 26% |
| Net Profit | 36 | 65 | 76 | 86 | 101 | 109 | 115 | 123 | 136 | 141 | 155 | 179 | 176 |
| EPS in Rs | 0.86 | 1.55 | 1.76 | 1.96 | 2.29 | 2.47 | 2.34 | 2.48 | 2.74 | 2.88 | 3.15 | 3.68 | 3.57 |
Last Updated: January 1, 2026, 11:16 am
Below is a detailed analysis of the quarterly data for Himadri Speciality Chemical Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,071.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,118.00 Cr. (Jun 2025) to 1,071.00 Cr., marking a decrease of 47.00 Cr..
- For Expenses, as of Sep 2025, the value is 838.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 873.00 Cr. (Jun 2025) to 838.00 Cr., marking a decrease of 35.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 233.00 Cr.. The value appears to be declining and may need further review. It has decreased from 245.00 Cr. (Jun 2025) to 233.00 Cr., marking a decrease of 12.00 Cr..
- For OPM %, as of Sep 2025, the value is 22.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 22.00%.
- For Other Income, as of Sep 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Jun 2025) to 36.00 Cr., marking an increase of 9.00 Cr..
- For Interest, as of Sep 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Jun 2025) to 15.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 17.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.00 Cr. (Jun 2025) to 17.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 237.00 Cr.. The value appears to be declining and may need further review. It has decreased from 241.00 Cr. (Jun 2025) to 237.00 Cr., marking a decrease of 4.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 26.00%.
- For Net Profit, as of Sep 2025, the value is 176.00 Cr.. The value appears to be declining and may need further review. It has decreased from 179.00 Cr. (Jun 2025) to 176.00 Cr., marking a decrease of 3.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 3.57. The value appears to be declining and may need further review. It has decreased from 3.68 (Jun 2025) to 3.57, marking a decrease of 0.11.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:15 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,395 | 1,437 | 1,182 | 1,341 | 2,022 | 2,422 | 1,806 | 1,679 | 2,791 | 4,172 | 4,185 | 4,613 | 4,465 |
| Expenses | 1,307 | 1,313 | 1,036 | 1,107 | 1,569 | 1,863 | 1,525 | 1,549 | 2,635 | 3,773 | 3,540 | 3,758 | 3,533 |
| Operating Profit | 88 | 124 | 146 | 233 | 452 | 560 | 280 | 131 | 156 | 399 | 645 | 854 | 932 |
| OPM % | 6% | 9% | 12% | 17% | 22% | 23% | 16% | 8% | 6% | 10% | 15% | 19% | 21% |
| Other Income | 13 | 13 | 9 | 6 | 12 | 8 | 8 | 14 | -17 | -2 | 43 | 52 | 88 |
| Interest | 118 | 103 | 111 | 82 | 70 | 71 | 55 | 33 | 36 | 66 | 64 | 45 | 51 |
| Depreciation | 58 | 59 | 67 | 33 | 33 | 34 | 39 | 47 | 50 | 51 | 50 | 55 | 61 |
| Profit before tax | -75 | -24 | -23 | 125 | 361 | 462 | 194 | 65 | 53 | 280 | 574 | 806 | 908 |
| Tax % | -22% | -49% | -19% | 34% | 31% | 30% | -6% | 27% | 27% | 23% | 28% | 31% | |
| Net Profit | -58 | -13 | -19 | 82 | 248 | 324 | 205 | 47 | 39 | 216 | 411 | 555 | 652 |
| EPS in Rs | -1.48 | -0.32 | -0.44 | 1.98 | 5.91 | 7.75 | 4.91 | 1.13 | 0.98 | 4.99 | 8.34 | 11.25 | 13.28 |
| Dividend Payout % | -7% | 0% | -11% | 5% | 2% | 2% | 3% | 13% | 20% | 5% | 6% | 5% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 77.59% | -46.15% | 531.58% | 202.44% | 30.65% | -36.73% | -77.07% | -17.02% | 453.85% | 90.28% | 35.04% |
| Change in YoY Net Profit Growth (%) | 0.00% | -123.74% | 577.73% | -329.14% | -171.79% | -67.37% | -40.34% | 60.05% | 470.87% | -363.57% | -55.24% |
Himadri Speciality Chemical Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 21% |
| 3 Years: | 18% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 22% |
| 3 Years: | 111% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 53% |
| 3 Years: | 65% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 15% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 6:10 am
Balance Sheet
Last Updated: December 10, 2025, 2:47 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 39 | 39 | 42 | 42 | 42 | 42 | 42 | 42 | 42 | 43 | 49 | 49 | 49 |
| Reserves | 757 | 750 | 837 | 988 | 1,373 | 1,590 | 1,692 | 1,751 | 1,826 | 2,237 | 2,996 | 3,672 | 4,020 |
| Borrowings | 1,362 | 1,124 | 887 | 774 | 660 | 476 | 505 | 729 | 587 | 842 | 605 | 313 | 864 |
| Other Liabilities | 339 | 329 | 296 | 308 | 341 | 680 | 323 | 269 | 999 | 555 | 798 | 621 | 585 |
| Total Liabilities | 2,497 | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 | 5,518 |
| Fixed Assets | 1,221 | 1,228 | 1,180 | 1,174 | 1,178 | 1,170 | 1,475 | 1,468 | 1,546 | 1,515 | 1,534 | 1,605 | 1,663 |
| CWIP | 59 | 14 | 31 | 13 | 22 | 133 | 158 | 160 | 77 | 94 | 67 | 185 | 443 |
| Investments | 168 | 23 | 53 | 87 | 273 | 179 | 47 | 66 | 113 | 132 | 478 | 582 | 723 |
| Other Assets | 1,048 | 977 | 798 | 838 | 943 | 1,305 | 882 | 1,098 | 1,718 | 1,938 | 2,371 | 2,283 | 2,688 |
| Total Assets | 2,497 | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 | 5,518 |
Below is a detailed analysis of the balance sheet data for Himadri Speciality Chemical Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 49.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 49.00 Cr..
- For Reserves, as of Sep 2025, the value is 4,020.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,672.00 Cr. (Mar 2025) to 4,020.00 Cr., marking an increase of 348.00 Cr..
- For Borrowings, as of Sep 2025, the value is 864.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 313.00 Cr. (Mar 2025) to 864.00 Cr., marking an increase of 551.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 585.00 Cr.. The value appears to be improving (decreasing). It has decreased from 621.00 Cr. (Mar 2025) to 585.00 Cr., marking a decrease of 36.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 5,518.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,656.00 Cr. (Mar 2025) to 5,518.00 Cr., marking an increase of 862.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,663.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,605.00 Cr. (Mar 2025) to 1,663.00 Cr., marking an increase of 58.00 Cr..
- For CWIP, as of Sep 2025, the value is 443.00 Cr.. The value appears strong and on an upward trend. It has increased from 185.00 Cr. (Mar 2025) to 443.00 Cr., marking an increase of 258.00 Cr..
- For Investments, as of Sep 2025, the value is 723.00 Cr.. The value appears strong and on an upward trend. It has increased from 582.00 Cr. (Mar 2025) to 723.00 Cr., marking an increase of 141.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,688.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,283.00 Cr. (Mar 2025) to 2,688.00 Cr., marking an increase of 405.00 Cr..
- For Total Assets, as of Sep 2025, the value is 5,518.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,656.00 Cr. (Mar 2025) to 5,518.00 Cr., marking an increase of 862.00 Cr..
Notably, the Reserves (4,020.00 Cr.) exceed the Borrowings (864.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 87.00 | 123.00 | -741.00 | -541.00 | -208.00 | 84.00 | -225.00 | -598.00 | -431.00 | -443.00 | 40.00 | 541.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 92 | 82 | 63 | 60 | 49 | 55 | 61 | 100 | 66 | 44 | 57 | 50 |
| Inventory Days | 134 | 122 | 138 | 164 | 112 | 124 | 121 | 100 | 125 | 61 | 85 | 68 |
| Days Payable | 36 | 36 | 50 | 74 | 39 | 100 | 68 | 45 | 127 | 39 | 69 | 28 |
| Cash Conversion Cycle | 191 | 168 | 151 | 150 | 122 | 79 | 113 | 155 | 65 | 66 | 73 | 90 |
| Working Capital Days | -11 | 4 | -22 | 19 | 29 | 40 | 10 | 15 | -1 | 1 | 32 | 69 |
| ROCE % | 2% | 3% | 5% | 11% | 22% | 25% | 11% | 4% | 5% | 13% | 19% | 22% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Quant ELSS Tax Saver Fund | 2,362,973 | 0.83 | 103.4 | N/A | N/A | N/A |
| Quant Small Cap Fund | 674,478 | 0.1 | 29.52 | N/A | N/A | N/A |
| Bandhan Infrastructure Fund | 106,723 | 0.3 | 4.67 | 234,368 | 2025-12-14 08:52:11 | -54.46% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 11.26 | 9.16 | 5.13 | 0.98 | 1.13 |
| Diluted EPS (Rs.) | 11.17 | 9.16 | 5.13 | 0.98 | 1.13 |
| Cash EPS (Rs.) | 12.35 | 9.35 | 6.16 | 2.11 | 2.25 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 75.37 | 61.77 | 52.64 | 44.51 | 42.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 75.37 | 61.77 | 52.64 | 44.51 | 42.78 |
| Revenue From Operations / Share (Rs.) | 93.41 | 84.96 | 96.41 | 66.62 | 40.09 |
| PBDIT / Share (Rs.) | 18.35 | 13.96 | 9.87 | 3.90 | 3.46 |
| PBIT / Share (Rs.) | 17.23 | 12.95 | 8.70 | 2.71 | 2.34 |
| PBT / Share (Rs.) | 16.33 | 11.65 | 6.48 | 1.28 | 1.54 |
| Net Profit / Share (Rs.) | 11.24 | 8.34 | 4.99 | 0.93 | 1.13 |
| NP After MI And SOA / Share (Rs.) | 11.25 | 8.34 | 4.99 | 0.97 | 1.13 |
| PBDIT Margin (%) | 19.63 | 16.43 | 10.23 | 5.84 | 8.63 |
| PBIT Margin (%) | 18.44 | 15.23 | 9.02 | 4.07 | 5.83 |
| PBT Margin (%) | 17.47 | 13.71 | 6.71 | 1.91 | 3.84 |
| Net Profit Margin (%) | 12.03 | 9.81 | 5.17 | 1.39 | 2.81 |
| NP After MI And SOA Margin (%) | 12.04 | 9.81 | 5.17 | 1.46 | 2.82 |
| Return on Networth / Equity (%) | 14.92 | 13.48 | 9.47 | 2.19 | 2.64 |
| Return on Capital Employeed (%) | 21.00 | 19.64 | 15.48 | 5.57 | 5.02 |
| Return On Assets (%) | 11.93 | 9.23 | 5.87 | 1.18 | 1.70 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.02 | 0.04 | 0.04 |
| Total Debt / Equity (X) | 0.08 | 0.19 | 0.36 | 0.30 | 0.37 |
| Asset Turnover Ratio (%) | 1.01 | 1.03 | 1.17 | 0.90 | 0.63 |
| Current Ratio (X) | 3.56 | 1.92 | 1.51 | 1.18 | 1.25 |
| Quick Ratio (X) | 2.59 | 1.33 | 1.07 | 0.63 | 0.84 |
| Inventory Turnover Ratio (X) | 7.16 | 4.92 | 4.99 | 4.30 | 3.13 |
| Dividend Payout Ratio (NP) (%) | 4.44 | 2.63 | 3.88 | 15.34 | 13.23 |
| Dividend Payout Ratio (CP) (%) | 4.04 | 2.34 | 3.14 | 6.94 | 6.65 |
| Earning Retention Ratio (%) | 95.56 | 97.37 | 96.12 | 84.66 | 86.77 |
| Cash Earning Retention Ratio (%) | 95.96 | 97.66 | 96.86 | 93.06 | 93.35 |
| Interest Coverage Ratio (X) | 20.23 | 10.77 | 6.47 | 4.58 | 4.34 |
| Interest Coverage Ratio (Post Tax) (X) | 13.40 | 7.43 | 4.72 | 2.79 | 2.41 |
| Enterprise Value (Cr.) | 20619.97 | 14725.34 | 3988.71 | 3425.68 | 2287.01 |
| EV / Net Operating Revenue (X) | 4.47 | 3.52 | 0.95 | 1.23 | 1.36 |
| EV / EBITDA (X) | 22.76 | 21.42 | 9.34 | 20.98 | 15.78 |
| MarketCap / Net Operating Revenue (X) | 4.54 | 3.55 | 0.90 | 1.12 | 1.04 |
| Retention Ratios (%) | 95.55 | 97.36 | 96.11 | 84.65 | 86.76 |
| Price / BV (X) | 5.62 | 4.88 | 1.66 | 1.67 | 0.97 |
| Price / Net Operating Revenue (X) | 4.54 | 3.55 | 0.90 | 1.12 | 1.04 |
| EarningsYield | 0.02 | 0.02 | 0.05 | 0.01 | 0.02 |
After reviewing the key financial ratios for Himadri Speciality Chemical Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 11.26. This value is within the healthy range. It has increased from 9.16 (Mar 24) to 11.26, marking an increase of 2.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is 11.17. This value is within the healthy range. It has increased from 9.16 (Mar 24) to 11.17, marking an increase of 2.01.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.35. This value is within the healthy range. It has increased from 9.35 (Mar 24) to 12.35, marking an increase of 3.00.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.37. It has increased from 61.77 (Mar 24) to 75.37, marking an increase of 13.60.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.37. It has increased from 61.77 (Mar 24) to 75.37, marking an increase of 13.60.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 93.41. It has increased from 84.96 (Mar 24) to 93.41, marking an increase of 8.45.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 18.35. This value is within the healthy range. It has increased from 13.96 (Mar 24) to 18.35, marking an increase of 4.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 17.23. This value is within the healthy range. It has increased from 12.95 (Mar 24) to 17.23, marking an increase of 4.28.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.33. This value is within the healthy range. It has increased from 11.65 (Mar 24) to 16.33, marking an increase of 4.68.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.24. This value is within the healthy range. It has increased from 8.34 (Mar 24) to 11.24, marking an increase of 2.90.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.25. This value is within the healthy range. It has increased from 8.34 (Mar 24) to 11.25, marking an increase of 2.91.
- For PBDIT Margin (%), as of Mar 25, the value is 19.63. This value is within the healthy range. It has increased from 16.43 (Mar 24) to 19.63, marking an increase of 3.20.
- For PBIT Margin (%), as of Mar 25, the value is 18.44. This value is within the healthy range. It has increased from 15.23 (Mar 24) to 18.44, marking an increase of 3.21.
- For PBT Margin (%), as of Mar 25, the value is 17.47. This value is within the healthy range. It has increased from 13.71 (Mar 24) to 17.47, marking an increase of 3.76.
- For Net Profit Margin (%), as of Mar 25, the value is 12.03. This value exceeds the healthy maximum of 10. It has increased from 9.81 (Mar 24) to 12.03, marking an increase of 2.22.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.04. This value is within the healthy range. It has increased from 9.81 (Mar 24) to 12.04, marking an increase of 2.23.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.92. This value is below the healthy minimum of 15. It has increased from 13.48 (Mar 24) to 14.92, marking an increase of 1.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is 21.00. This value is within the healthy range. It has increased from 19.64 (Mar 24) to 21.00, marking an increase of 1.36.
- For Return On Assets (%), as of Mar 25, the value is 11.93. This value is within the healthy range. It has increased from 9.23 (Mar 24) to 11.93, marking an increase of 2.70.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.08. This value is within the healthy range. It has decreased from 0.19 (Mar 24) to 0.08, marking a decrease of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.01. It has decreased from 1.03 (Mar 24) to 1.01, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 3.56. This value exceeds the healthy maximum of 3. It has increased from 1.92 (Mar 24) to 3.56, marking an increase of 1.64.
- For Quick Ratio (X), as of Mar 25, the value is 2.59. This value exceeds the healthy maximum of 2. It has increased from 1.33 (Mar 24) to 2.59, marking an increase of 1.26.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.16. This value is within the healthy range. It has increased from 4.92 (Mar 24) to 7.16, marking an increase of 2.24.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.44. This value is below the healthy minimum of 20. It has increased from 2.63 (Mar 24) to 4.44, marking an increase of 1.81.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.04. This value is below the healthy minimum of 20. It has increased from 2.34 (Mar 24) to 4.04, marking an increase of 1.70.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.56. This value exceeds the healthy maximum of 70. It has decreased from 97.37 (Mar 24) to 95.56, marking a decrease of 1.81.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.96. This value exceeds the healthy maximum of 70. It has decreased from 97.66 (Mar 24) to 95.96, marking a decrease of 1.70.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 20.23. This value is within the healthy range. It has increased from 10.77 (Mar 24) to 20.23, marking an increase of 9.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 13.40. This value is within the healthy range. It has increased from 7.43 (Mar 24) to 13.40, marking an increase of 5.97.
- For Enterprise Value (Cr.), as of Mar 25, the value is 20,619.97. It has increased from 14,725.34 (Mar 24) to 20,619.97, marking an increase of 5,894.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.47. This value exceeds the healthy maximum of 3. It has increased from 3.52 (Mar 24) to 4.47, marking an increase of 0.95.
- For EV / EBITDA (X), as of Mar 25, the value is 22.76. This value exceeds the healthy maximum of 15. It has increased from 21.42 (Mar 24) to 22.76, marking an increase of 1.34.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.54. This value exceeds the healthy maximum of 3. It has increased from 3.55 (Mar 24) to 4.54, marking an increase of 0.99.
- For Retention Ratios (%), as of Mar 25, the value is 95.55. This value exceeds the healthy maximum of 70. It has decreased from 97.36 (Mar 24) to 95.55, marking a decrease of 1.81.
- For Price / BV (X), as of Mar 25, the value is 5.62. This value exceeds the healthy maximum of 3. It has increased from 4.88 (Mar 24) to 5.62, marking an increase of 0.74.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.54. This value exceeds the healthy maximum of 3. It has increased from 3.55 (Mar 24) to 4.54, marking an increase of 0.99.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Himadri Speciality Chemical Ltd:
- Net Profit Margin: 12.03%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.92% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 13.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.59
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 38 (Industry average Stock P/E: 67.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.08
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.03%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Carbon Black | Fortuna Tower, 23-A, Netaji Subhas Road, Kolkata West Bengal 700001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anurag Choudhary | Chairman & M.D & CEO |
| Mr. Shyam Sundar Choudhary | Executive Director |
| Mr. Amit Choudhary | Executive Director |
| Mr. Girish Paman Vanvari | Independent Director |
| Mr. Gopal Ajay Malpani | Independent Director |
| Ms. Rita Bhattacharya | Independent Director |
| Mr. Amitabh Srivastava | Independent Director |
FAQ
What is the intrinsic value of Himadri Speciality Chemical Ltd?
Himadri Speciality Chemical Ltd's intrinsic value (as of 02 January 2026) is ₹410.81 which is 16.84% lower the current market price of ₹494.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹24,923 Cr. market cap, FY2025-2026 high/low of ₹607/351, reserves of ₹4,020 Cr, and liabilities of ₹5,518 Cr.
What is the Market Cap of Himadri Speciality Chemical Ltd?
The Market Cap of Himadri Speciality Chemical Ltd is 24,923 Cr..
What is the current Stock Price of Himadri Speciality Chemical Ltd as on 02 January 2026?
The current stock price of Himadri Speciality Chemical Ltd as on 02 January 2026 is ₹494.
What is the High / Low of Himadri Speciality Chemical Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Himadri Speciality Chemical Ltd stocks is ₹607/351.
What is the Stock P/E of Himadri Speciality Chemical Ltd?
The Stock P/E of Himadri Speciality Chemical Ltd is 38.0.
What is the Book Value of Himadri Speciality Chemical Ltd?
The Book Value of Himadri Speciality Chemical Ltd is 82.3.
What is the Dividend Yield of Himadri Speciality Chemical Ltd?
The Dividend Yield of Himadri Speciality Chemical Ltd is 0.12 %.
What is the ROCE of Himadri Speciality Chemical Ltd?
The ROCE of Himadri Speciality Chemical Ltd is 22.0 %.
What is the ROE of Himadri Speciality Chemical Ltd?
The ROE of Himadri Speciality Chemical Ltd is 16.4 %.
What is the Face Value of Himadri Speciality Chemical Ltd?
The Face Value of Himadri Speciality Chemical Ltd is 1.00.